GSR III ACQUISITION CORP (GSRT) Fundamental Analysis & Valuation

NASDAQ:GSRT • KYG4R1031072

Current stock price

15.52 USD
+1 (+6.89%)
At close:
16.25 USD
+0.73 (+4.7%)
After Hours:

This GSRT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. GSRT Profitability Analysis

1.1 Basic Checks

  • In the past year GSRT was profitable.
  • In the past year GSRT has reported a negative cash flow from operations.
GSRT Yearly Net Income VS EBIT VS OCF VS FCFGSRT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 0 500K -500K

1.2 Ratios

Industry RankSector Rank
ROA 1.71%
ROE 1.78%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GSRT Yearly ROA, ROE, ROICGSRT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 0 -50 -100 -150

1.3 Margins

  • GSRT does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GSRT Yearly Profit, Operating, Gross MarginsGSRT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. GSRT Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, GSRT has more shares outstanding
  • There is no outstanding debt for GSRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
GSRT Yearly Shares OutstandingGSRT Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 5M 10M 15M 20M 25M
GSRT Yearly Total Debt VS Total AssetsGSRT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 50M 100M 150M 200M

2.2 Solvency

  • GSRT has an Altman-Z score of 31.67. This indicates that GSRT is financially healthy and has little risk of bankruptcy at the moment.
  • There is no outstanding debt for GSRT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 31.67
ROIC/WACCN/A
WACCN/A
GSRT Yearly LT Debt VS Equity VS FCFGSRT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.10 indicates that GSRT should not have too much problems paying its short term obligations.
  • GSRT has a Quick Ratio of 1.10. This is a normal value and indicates that GSRT is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
GSRT Yearly Current Assets VS Current LiabilitesGSRT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 500K 1M 1.5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. GSRT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 6850.00% over the past year.
EPS 1Y (TTM)6850%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5533.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • GSRT is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -84.51% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-276.3%
EPS Next 2Y-129.65%
EPS Next 3Y-84.51%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GSRT Yearly EPS VS EstimatesGSRT Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

0

4. GSRT Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 103.47, GSRT can be considered very expensive at the moment.
  • Compared to an average S&P500 Price/Earnings ratio of 26.54, GSRT is valued quite expensively.
  • The Forward Price/Earnings Ratio is negative for GSRT. No positive earnings are expected for the next year.
Industry RankSector Rank
PE 103.47
Fwd PE N/A
GSRT Price Earnings VS Forward Price EarningsGSRT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 100 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GSRT Per share dataGSRT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

  • GSRT's earnings are expected to decrease with -84.51% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-129.65%
EPS Next 3Y-84.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GSRT Dividend Analysis

5.1 Amount

  • No dividends for GSRT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

GSRT Fundamentals: All Metrics, Ratios and Statistics

GSR III ACQUISITION CORP

NASDAQ:GSRT (10/9/2025, 9:16:17 PM)

After market: 16.25 +0.73 (+4.7%)

15.52

+1 (+6.89%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)08-11
Earnings (Next)12-15
Inst Owners58.29%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap532.96M
Revenue(TTM)N/A
Net Income(TTM)4.05M
Analysts82.5
Price Target19.89 (28.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.63%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 103.47
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.35
P/tB 2.35
EV/EBITDA N/A
EPS(TTM)0.15
EY0.97%
EPS(NY)-0.13
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0
BVpS6.62
TBVpS6.62
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.72505 (-69.56%)
Profitability
Industry RankSector Rank
ROA 1.71%
ROE 1.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 31.67
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6850%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%5533.33%
EPS Next Y-276.3%
EPS Next 2Y-129.65%
EPS Next 3Y-84.51%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2704.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-1004.19%
EBIT Next 3Y-253.25%
EBIT Next 5YN/A
FCF growth 1Y-2114.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2114.4%
OCF growth 3YN/A
OCF growth 5YN/A

GSR III ACQUISITION CORP / GSRT Fundamental Analysis FAQ

What is the fundamental rating for GSRT stock?

ChartMill assigns a fundamental rating of 2 / 10 to GSRT.


What is the valuation status for GSRT stock?

ChartMill assigns a valuation rating of 0 / 10 to GSR III ACQUISITION CORP (GSRT). This can be considered as Overvalued.


Can you provide the profitability details for GSR III ACQUISITION CORP?

GSR III ACQUISITION CORP (GSRT) has a profitability rating of 0 / 10.


Can you provide the financial health for GSRT stock?

The financial health rating of GSR III ACQUISITION CORP (GSRT) is 5 / 10.